In a regulatory filing, Amneal Pharmaceuticals (AMRX) director Gautam Patel disclosed the sale of 62,590 class A common shares of the company on January 8 at a price of $8.01 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
Questions or Comments about the article? Write to editor@tipranks.com